patients with non–small cell lung cancer treated using atezolizumab monotherapy, we analyzed the incidence, severity, time course, treatment, outcomes, and risk factors of various organ-specific irAEs and their relationships with response rates
Search Results
Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni, Andrew Rowland, Ashley M. Hopkins, and Michael J. Sorich
Nisar Ahmad, Denise M. Adams, Jiang Wang, Rajan Prakash, and Nagla Abdel Karim
,000. 3 It is slightly more common in women, with a female-to-male ratio of approximately 1.6:1.0. Risk factors for HEHE are not well-known. An association of HEHE with oral contraceptives has been suggested but not completely established. 4 , 5 HEHE
Anusha Ponduri, David Z. Liao, Nicolas F. Schlecht, Gregory Rosenblatt, Michael B. Prystowsky, Rafi Kabarriti, Madhur Garg, Thomas J. Ow, Bradley A. Schiff, Richard V. Smith, and Vikas Mehta
intervene in a prospective fashion. In this study, we sought to measure the impact of nonadherence to NCCN Guidelines on survival and disease recurrence in patients with HNSCC at a large urban health center, and investigated risk factors predictive of delay
Taymeyah Al-Toubah, Eleonora Pelle, Tiffany Valone, Mintallah Haider, and Jonathan R. Strosberg
gastrointestinal NETs. Although moderately powered studies are sufficient to determine critical outcomes such as ORR and PFS, larger databases are key to answering other important questions. These include the frequency of rare toxicities, risk factors for
Elizabeth A. Rohan, Julie S. Townsend, Temeika L. Fairley, and Sherri L. Stewart
addressed in interventions. Methods Behavioral Risk Factor Surveillance System Survey This study used the Behavioral Risk Factor Surveillance System (BRFSS), a state-based system of health surveys that collects information on health risk
Paul G. Richardson, Jacob P. Laubach, Robert L. Schlossman, Constantine Mitsiades, and Kenneth Anderson
neuropathy may be detected in 11% to 52% and 39% to 46% of these populations, respectively. 1 – 6 Risk factors for PN include treatment-specific characteristics, such as therapy duration, dose intensity, and cumulative dose, and patient-specific factors
Margaret R. O’Donnell
“In the majority of our patients, the major risk factor for whether they will do well or poorly is related to their cytogenetic and/or molecular markers,” stated Margaret R. O’Donnell, MD, Associate Clinical Director, Division of Hematology and
Nina N. Sanford, David J. Sher, Xiaohan Xu, Chul Ahn, Anthony V. D’Amico, Ayal A. Aizer, and Brandon A. Mahal
Background Alcohol use has been identified as a risk factor for several malignancies, including cancers of the head and neck, esophagus, colorectum, liver, and breast. 1 – 3 Epidemiologic studies have shown that higher alcohol consumption over
Robert Torrey, Philippe E. Spiess, Sumanta K. Pal, and David Josephson
study from MD Anderson Cancer Center, adverse risk factors were described as positive local recurrence margin, increased size of recurrence, presence of sarcomatoid features, and abnormal serum alkaline phosphatase or lactate dehydrogenase. Patients with
Andrea K. Ng and Lois B. Travis
.9%. 61 Although these excesses are largely related to preexisting breast cancer risk factors, prior radiation therapy, especially treatment at a young age, may contribute to the increased risk. 28 - 30 , 62 In early case-control studies by Storm et al
